• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    AI Drug Discovery Companies

    ID: MRFR/Pharma/7918-CR
    200 Pages
    Rahul Gotadki
    July 2023

    AI in drug discovery has become a transformative force, revolutionizing the pharmaceutical industry by accelerating the drug development process, reducing costs, and improving the efficiency of drug discovery pipelines. Numerous companies are leveraging artificial intelligence (AI) and machine learning (ML) technologies to streamline various aspects of drug discovery, from target identification and lead optimization to clinical trial design and personalized medicine

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Artificial Intelligence (AI) in Drug Discovery Market Research Report - Forecast to 2035 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the AI Drug Discovery Market

    Artificial Intelligence in Drug Discovery Key Companies

     


    Latest Artificial Intelligence in Drug Discovery Companies Update:

    Exscientia expands collaboration with Merck KGaA: This multi-year partnership leverages Exscientia's AI-powered drug design platform to discover small molecule drug candidates across several therapeutic areas like oncology, neuroinflammation, and immunology.


    BenevolentAI partners with AstraZeneca: This collaboration utilizes BenevolentAI's AI platform to analyze vast datasets and identify promising drug targets for neurodegenerative diseases, aiming to accelerate preclinical research.


    Intellia Therapeutics collaborates with Verily Life Sciences: This partnership combines Intellia's CRISPR gene editing technology with Verily's AI and data analytics expertise to optimize gene editing therapies for targeted diseases.


    List of Artificial Intelligence in Drug Discovery Key companies in the market

    • IBM (US)

    • Alphabet Inc (US)

    • Atomwise Inc (US)

    • Deep Genomics (Canada)

    • Cloud Pharmaceuticals, Inc (US)

    • Microsoft corporation (US)

    • Insilico Medicine (China)

    • Cyclica (Canada)

    • BenevolentAI (UK)

    • Exscientia (UK)